Tratamiento Inhalado Israelí ( EXO-CD24 ) Está Ya en Fase III se Centra en Detener la " Tormenta de Citocinas " Que Afecta a los Pulmones de Algunos Pacientes ... AstraZeneca Podría Estar Interesada .

Covid Inhaler Firm Seeks Big Backer To Develop Its Treatment .

An Israeli doctor working on an experimental treatment for Covid is looking to team up with the world's largest pharmaceutical firms, such as AstraZeneca, to develop the treatment.

Nadir Arber has been working on a drug called EXO-CD24 that could turn severe cases of Covid-19 into manageable medical events. 

The drug, now in a phase-three trial, focuses on stopping the 'cytokine storm' that affects the lungs of some patients. ...